Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'fda'
fda published presentations and documents on DocSlides.
Reigniting innovation in antibiotics
by jones
When to Push and when to Pull. John H. Rex, MD. Ed...
Acknowledgments References
by martin
Purpose. Cancellation of ordered gadolinium-based ...
Personalized Medicine &
by ashley
Pharmacogenomics. Created by the School of Pharmac...
Neurodevelopmental Impact of Anesthetics in Pediatric Patients: 2019 Update
by gabriella
Zhe. Chen, MD . Assistant Clinical Professor . An...
SSRL Industry Engagement
by anderson
Paul McIntyre. December 17, 2020. 2. SSRL Mission:...
Figure 4-3. Process for perinatal hepatitis C case ascertainment and classification
by lam
*Test. . results. . among infants. . <2 mont...
SUPPLEMENT SAFETY AND REGULATION
by sophia
Lecture content provided by GSSI, a division of Pe...
Human Subjects Protection Training:
by reagan
For VA Personnel Conducting Expanded Access Progra...
Introduction to flood risk assessment with HEC-FDA
by smith
Richard J. Nugent III, Ph.D. . Economist, HEC-FDA ...
ASTA Legislative and Legal Concerns Committee
by bety
& . OSA Legislative Committee. GMO Labeling Le...
What Clinicians Want to Know:
by violet
Understanding the Factors Affecting the Optimal Di...
COVID-19 Vaccine: answers to your questions
by clara
A presentation for Staff and residents in post-acu...
Soft Lights Foundation The Hazards of Light
by bitsy
Emitting Diode Products. www.softlights.org. https...
Welcome : New Resources for Designing & Running
by barbara
Master . Protocols. This webinar is being recorded...
AIDS ACTION BALTIMORE TOWN HALL
by ashley
COVID-19VACCINES. AIDS ACTION BALTIMORE. Lynda Dee...
Team NASA Assaf Anyamba Jennifer Small
by anderson
Richard Damoah. (GSFC). FDA. David . Oryang. . We...
Understanding Data Registry Setup and Maintenance
by joy
Policies. Nichole Haywood. IRB Protocol Analyst. P...
MANAGING SPONSOR RESPONSIBILITIES FOR FEDERALLY-FUNDED RESEARCH
by hadly
Presented by the . Research Quality Compliance Net...
Requirement for Investigators and Sub-Investigators to File Financial Disclosure Forms
by lydia
Investigator of Record – Definition. “The indi...
Vernon D. Toelle, Ph.D. Team Leader
by ani
Pre-Market Compliance and . Administrative Actions...
FDA Approved Cannabis Products
by brooke
Marinol and . Syndros. (synthetic THC Max daily 2...
LDMS Validation and Audit Readiness
by emma
Software Validation. Software validation checks th...
Chimeric Antigen Receptor
by jordyn
T-Cell Therapy:. The Basics. Jennifer Mann MSN, AN...
Outcomes: MDA-NINDS Workshop on Best Practices for Gene Therapy Programs (April 2014)
by dora
(…and NINDS’ Adaptations). John D. Porter, Ph....
Head of Statistics nQuery
by jade
Lead Researcher. FDA Guest Speaker. Guest Lecturer...
Co-occurring Disorders Oluwole Jegede MD MPH
by ceila
Brian Fuehrlein MD PhD. YALE UNIVERSITY SCHOOOL OF...
RADx-UP CDCC Rapid Research Pilot Program (RP2)
by stella
Agenda. Topic. Discussion Leader. Time. Welcome. R...
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P
by ava
) Work Group. Co-Chairs: Paul Ashford, Executive...
Table 4-1. Interpretation of hepatitis C laboratory results
by bethany
Test. . Outcome*. Interpretation†. Further. . ...
Category 1: Defining Terms
by jasmine
Clue: . A biologic product with no clinically mean...
BIOPROCESS TECHNOLOGY (MBT-303)
by emery
Prof. . R.K.Gaur. Introduction. Fields of study. :...
Suzanne B. Merrill, M.D., F.A.C.S.
by harper
Urologic Oncologist. Colorado Urology. Bladder Can...
Chapter 24 Food Additives
by phoebe
By: Lexi Carp, Devon . Grissinger. , and Nina . Sa...
1 *Additional FDA recommendation details
by elise
here. Pregnancy Planning for . WOMEN. with Psoria...
Falck Medical Multi-Function DEVICE
by sophie
COPYRIGHT 2020 . FAT1 Device. First Artificially I...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Herbs and Oils: What’s
by piper
the Latest?. John D. Mark MD. Russell Wise . Pharm...
Session 8: Study Start-up: Part 2
by gabriella
Derita: . dbran@uthsc.edu. Margaret: . mlynn@ut...
Chapter 11: Pharmaceuticals
by garcia
Continued. Pharmaceutical Discoveries and Problems...
Routine Annual Health Visit
by ashley
Feline Nematode infection. History and Signalment....
Load More...